Conference call "Novartis committed to making Galvus available for patients with type 2 diabetes after US regulators issue "approvable letter""
26/2/2007
Archive Novartis results
Read the quarterly and full-year results of Novartis from years past
Governance Documents
Read, print or download important documents on Novartis Corporate Governance.
Financial Publications & Events
Downloadable information and webcasts on our quarterly and full year results, upcoming and past events and conferences.
IR Contacts
Download or order a copy of our annual report; or find contact information for our Investor Relations personnel.
Newsroom
Exforge® receives US regulatory approval as a new and highly effective treatment option for patients with high blood pressure... read more ›
Annual General Meeting
Notice of Annual General Meeting, 6 March 2007
More ›
ABOUT NOVARTIS
On March 7th, 1996 Sandoz and Ciba-Geigy, the two Swiss-based chemical/life sciences giants, became Novartis.
Research
Novartis is working to build the most promising pipeline in the industry to treat and help people around the world.